Immuno-Oncology Therapy Essentials: Proactive Management of Immune-Related Adverse Events

This activity, certified for CME/CE/CPE credit, is jointly provided by
image
image
image

Immuno-Oncology Therapy Essentials: Proactive Management of Immune-Related Adverse Events

A continuing education activity for nurse practitioners, PAs, clinical nurse specialists, advanced degree nurses, oncology and hematology nurses, pharmacists, and physicians.

Release date: March 21, 2019

Expiration date: March 21, 2020

Estimated time to complete activity: 3.0 hours

Certified for CE by:

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Drive, Dinah Shore Bldg.
Rancho Mirage, CA 92270
Voice: 760-773-4500
Fax: 760-773-4513
E-mail: contactce@annenberg.net

© 2019, Annenberg Center for Health Sciences at Eisenhower. All rights reserved.

In collaboration with:

AIM With Immunotherapy Foundation
139 Waterside Circle
San Rafael, CA 94903
Voice: 916-706-0599
E-mail: vguild@aimatmelanoma.org

Journal of the Advanced Practitioner in Oncology
94 North Woodhull Road
Huntington, NY 11743
Voice: 631-692-0800
Fax: 631-692-0805
E-mail: editor@advancedpractitioner.com

Terranova Medica, LLC
564 Vista Grande Drive
Colorado Springs, CO 80906
Voice/Fax: 877-276-4523
E-mail: tdavis@terranovamedica.com

This certified activity is supported by an educational grant from Merck & Co., Inc.

Faculty

Marianne J. Davies, DNP, MSN, RN, APRN, CNS-BC, ACNP-BC, AOCNP®, Yale School of Nursing, Yale University, New Haven, Connecticut

Casey Fazer, PA-C, Mayo Clinic, Rochester, Minnesota

Brianna Hoffner, MSN, ANP-BC, AOCNP® (Chairperson), University of Colorado Cancer Center, Aurora

Krista M. Rubin, MS, FNP-BC, Center for Melanoma, Massachusetts General Hospital, Boston, Massachusetts

Laura S. Wood, RN, MSN, OCN®, Cleveland Clinic Cancer Center, Cleveland, Ohio

Intended Audience

The activity’s target audience will consist of nurse practitioners, physician assistants, clinical nurse specialists, advanced degree nurses, oncology and hematology nurses, pharmacists, and physicians.

Activity Rationale and Purpose

The management of immune-related adverse events (irAEs) represents a major challenge for the oncology advanced practice provider. This supplement illustrates the application of the Immuno-Oncology Essentials resources across tumor types, with a particular emphasis on incorporation of the Care Step Pathways (CSPs) for identification, grading, and management of irAEs. These articles highlight the essential role of the advanced practice provider for educating patients and owning the triage, identification, and management of irAEs.

Learning Objectives

After completing this educational activity, participants should be able to:

  1. Discuss the use of immune checkpoint inhibitors across tumor types
  2. Evaluate staff and institutional resources involved with the adequate triage of immune-related adverse events associated with immune checkpoint inhibitors
  3. Identify, grade, and manage irAEs associated with immune checkpoint inhibitors
  4. Educate and counsel patients to be active participants in the identification and management of immune-related adverse events associated with immune checkpoint inhibitors

Continuing Education

Statement of Credit—Participants who successfully complete this activity (including the submission of the post-test and evaluation form) will receive a statement of credit.

image

Physicians.This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower, the Advanced Practitioner Society for Hematology and Oncology, and the Journal of the Advanced Practitioner in Oncology. The Annenberg Center is accredited by the ACCME to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

image

Nurses. Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

A maximum of 3.0 contact hours, which includes 2.5 hours of pharmacology, may be earned for successful completion of this activity.

Provider is approved by the California Board of Registered Nursing, Provider No. 13664, for 3.0 contact hours.

image

Pharmacists. The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program has been assigned ACPE Universal Program #0797-9999-19-019-H01-P. This program is designated for up to 3.0 contact hours (0.30 CEUs) of continuing pharmacy education credit.

Financial Disclosures

All individuals in positions to control the content of this program (e.g., planners, faculty, content reviewers) are expected to disclose all financial relationships with commercial interests that may have a direct bearing on the subject matter of this continuing education activity. Annenberg Center for Health Sciences at Eisenhower has identified and resolved all conflicts of interest in accordance with the ACHS policies and procedures. Participants have the responsibility to assess the impact (if any) of the disclosed information on the educational value of the activity.

Disclosures

Faculty

Marianne J. Davies, DNP, MSN, RN, APRN, CNS-BC, ACNP-BC, AOCNP®, has served on speakers bureaus for AstraZeneca, Bristol-Myers Squibb, Genentech, and Merck.

Casey Fazer, PA-C, has nothing to disclose.

Brianna Hoffner, MSN, ANP-BC, AOCNP® (Chairperson), has served on advisory boards for Bristol-Myers Squibb and Merck.

Krista M. Rubin, MS, FNP-BC, has served on advisory boards for Bristol-Myers Squibb and Merck.

Laura S. Wood, RN, MSN, OCN®, has served on speakers bureaus for Bristol-Myers Squibb, Genentech, and Pfizer.

Annenberg Center for Health Sciences at Eisenhower

Staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Lead Nurse Planner

Dorothy Caputo, MA, BSN, RN, has nothing to disclose

Harborside

Harborside staff have no potential conflicts of interest to disclose.

Terranova Medica LLC

Michael Coco, PhD, has nothing to disclose.

Sharon Cross, PhD, has nothing to disclose.

Lisa Tushla, PhD, H(ASCP), has nothing to disclose.

Content Reviewers

Andrea Edwards, PA-C, has served as a speaker for Pfizer.

Nancy Nix, PharmD, BCPS, BCOP, has nothing to disclose.

Pamela Viale, RN, MS, CNS, ANP, has nothing to disclose.

Laura Zitella, MS, RN, ACNP-BC, AOCN®, has served as a consultant for AbbVie, Amgen, Array BioPharma, AstraZeneca, Gilead, and Merck.

Disclaimer

This activity has been designed to provide continuing education that is focused on specific objectives. In selecting educational activities, clinicians should pay special attention to the relevance of those objectives and the application to their particular needs. The intent of all Annenberg Center for Health Sciences at Eisenhower educational opportunities is to provide learning that will improve patient care. Clinicians are encouraged to reflect on this activity and its applicability to their own patient population.

The opinions expressed in this activity are those of the faculty and reviewers and do not represent an endorsement by Annenberg Center for Health Sciences at Eisenhower of any specific therapeutics or approaches to diagnosis or patient management.

Product Disclosure

This educational activity may contain discussion of published as well as investigational uses of agents that are not approved by the U.S. Food and Drug Administration. For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the prescribing information for each product.

How to Earn Statement of Credit

Statement of Credit: Participants who successfully complete this activity (including scoring of a minimum of 70% on the learning assessment) and complete and submit the evaluation form will be able to download a statement of credit.

Course summary
Available credit: 
  • 2.50 Pharmacology
  • 3.00 ACPE
  • 3.00 AMA PRA Category 1 Credit(s)™
  • 3.00 Attendance
  • 3.00 CA-BRN
  • 3.00 ANCC
Course opens: 
03/21/2019
Course expires: 
03/21/2020
Cost:
$0.00
Rating: 
0

Available Credit

  • 2.50 Pharmacology
  • 3.00 ACPE
  • 3.00 AMA PRA Category 1 Credit(s)™
  • 3.00 Attendance
  • 3.00 CA-BRN
  • 3.00 ANCC

Accreditation Period

Course opens: 
03/21/2019
Course expires: 
03/21/2020

Price

Cost:
$0.00
Please login or register to take this course.